Navigation Links
Concord Medical Declares Special Dividend
Date:1/7/2014

BEIJING, Jan. 7, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital, today announced that on January 7, 2014, its Board of Directors declared a special cash dividend of $0.24 per ordinary share (or $0.72 per American Depositary Share ("ADS")) on the Company's outstanding ordinary shares. The total expense for the special dividend is expected to be approximately $32.2 million, based on 134,018,937 ordinary shares outstanding as of September 30, 2013. Each ADS represents three ordinary shares of the Company.

The dividends are payable on January 30, 2014, to shareholders of record at the close of business on January 20, 2014.

Dr. Jianyu Yang, Chairman and CEO of the Company, said, "The Board of Directors declared this special dividend to provide shareholders with a tangible recognition of our good growth and solid financial performance. Concord Medical is well positioned to maintain its leadership in the fast-growing healthcare services sector in China. The Company is expected to return exceptional values to shareholders, while maintain a stable growth prospect in our business."

About Concord Medical

Concord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in China, measured by revenues and the number of centers in operation and is the parent of Chang'an Hospital. As of September 30, 2013, the Company operated a network of 144 centers with 78 hospital partners that spanned 55 cities and 24 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

For more information, please contact:

Mr. Adam J. Sun (Chinese and English)
+86 10 5957 5266
adam.sun@concordmedical.com

Mr. Ting Jia (Chinese and English)
+86 10 5903 6688 (ext. 809)
ting.jia@concordmedical.com

Ms. Gloria Huang (Chinese and English)
+86 10 5903 6688 (ext. 639)
gloria.huang@concordmedical.com

ICR Inc.

In China: 
Ms. Rene Jiang 
+86 10 6583-7521 
rene.jiang@icrinc.com

In the United States: 
Mr. William Zima
+1 203-682-8233
William.Zima@icrinc.com


'/>"/>
SOURCE Concord Medical Services Holdings Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Concord Medical Announces Results of 2013 Annual General Meeting; Appoints New Board Members
2. Concord Medical Announces the Closing of Acquisition of Its Shares by CEO and COO from Other Shareholders
3. Concord Medical Signs MOU with Shanghai New Hongqiao International Medical Center and GE Healthcare to Establish a Medical Imaging Diagnosis Center
4. Concord Medical Reports Third Quarter 2013 Financial Results and Reiterates Financial Year Guidance Forecast
5. Concord Medical to Report Third Quarter 2013 Financial Results on November 12, 2013
6. Concord Medical Announces Acquisition of Its Shares by CEO and COO from Other Shareholders
7. Concord Medical Reports Second Quarter 2013 Financial Results
8. Concord Medical to Report Second Quarter 2013 Financial Results on Aug 12, 2013
9. Concord Medical Announces Launch of Mobile Health Application
10. Concord Medical Reports First Quarter 2013 Financial Results
11. Concord Medical Announces the Signing of US$50 Million IFC Loan Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):